Nicholas Fidelman, MD

Professor
Director of Interventional Oncology
Professor of Clin Radiology
View full UCSF Profile

Biography

Nicholas Fidelman, MD, is a Professor of Clinical Radiology at the University of California, San Francisco and UCSF Mount Zion. Dr. Fidelman received his medical degree from UCSF in 2002, and completed his residency in Diagnostic Radiology from UCSF in 2007, followed by a fellowship in Interventional Radiology from UCSF in 2008.

Dr. Fidelman’s research interest is focused on determining the outcomes of many commonly performed procedures in Interventional Radiology, and on improving the safety and efficacy of imaging-guided interventions. One of Dr. Fidelman’s interventional oncology projects currently focuses on Yttrium-90 liver radioembolization in patients with primary and secondary liver malignancies and on safety of chemoembolization in patients with primary liver cancer and marginal liver reserve.

Other ongoing projects are focused on biliary procedures, elucidating the role of percutaneous cholangiography and biliary drainage in management of patients with biliary complications after living-related liver transplantation, and determining optimal treatment for patients with malignant hilar bile duct obstruction. Dr. Fidelman has over 30 research publications, including comparative and evaluation studies.

Expertise:
Interventional Radiology

Specialty:
Angiography, interventional oncology, liver and bile ducts, hepatocellular carcinoma, chemoembolization, radioembolization

Professional Interests:
Radioembolization, chemoembolization, radiofrequency ablation, biliary interventions, genitourinary interventions, gynecologic interventions, and uterine fibroid embolization

Education and Training:
• Medical School: University of California, San Francisco
• Internship: St. Mary’s Medical Center, San Francisco - Internal Medicine
• Residency: University of California, San Francisco - Diagnostic Radiology
• Fellowship: University of California, San Francisco - Interventional Radiology
• Diplomat of the American Board of Radiology
• Certificate of Additional Qualification in Vascular and Interventional Radiology

Education

05/2021 - Diversity, Equity, and Inclusion Champion Training, University of California, San Francisco
M.D., 2002 - Medicine, University of California, San Francisco

Honors and Awards

Research Fellowship, American Heart Association, 1999

Publications

Khanjyan MV, Fidelman N. Intra-arterial Peptide Receptor Radionuclide Therapy for the Treatment of Hepatic Neuroendocrine Tumor Metastases: Hope or Hype? Semin Intervent Radiol. 2024 Feb; 41(1):11-15.
Rabei R, Fidelman N. Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy. Curr Treat Options Oncol. 2023 12; 24(12):1994-2004.
Hassan OT, Behr SC, Ohliger MA, Fowler KJ, Gill RM, Fidelman N, Mehta N, Choi HH. Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma. Radiology. 2023 12; 309(3):e222776.
Mendiratta-Lala M, Aslam A, Bai HX, Chapiro J, De Baere T, Miyayama S, Chernyak V, Matsui O, Vilgrain V, Fidelman N. Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization. Eur Radiol. 2024 May; 34(5):3284-3297.
Expert Panels on Interventional Radiology and Vascular Imaging, Higgins MCSS, Diamond M, Mauro DM, Kapoor BS, Steigner ML, Fidelman N, Aghayev A, Chamarthy MRK, Dedier J, Dillavou ED, Felder M, Lew SQ, Lockhart ME, Siracuse JJ, Dill KE, Hohenwalter EJ. ACR Appropriateness Criteria® Dialysis Fistula Malfunction. J Am Coll Radiol. 2023 11; 20(11S):S382-S412.
Expert Panels on Interventional Radiology and Vascular Imaging, Rochon PJ, Reghunathan A, Kapoor BS, Kalva SP, Fidelman N, Majdalany BS, Abujudeh H, Caplin DM, Eldrup-Jorgensen J, Farsad K, Guimaraes MS, Gupta A, Higgins M, Kendi AT, Khilnani NM, Patel PJ, Dill KE, Hohenwalter EJ. ACR Appropriateness Criteria® Lower Extremity Chronic Venous Disease. J Am Coll Radiol. 2023 11; 20(11S):S481-S500.
Yu Q, Khanjyan M, Fidelman N, Pillai A. Contemporary applications of Y90 for the treatment of hepatocellular carcinoma. Hepatol Commun. 2023 10 01; 7(10).
Wu X, Kwong A, Heller M, Lokken RP, Fidelman N, Mehta N. Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant. Liver Transpl. 2024 02 01; 30(2):151-159.
Expert Panel on Interventional Radiology, Massouh A, Kwan SW, Fidelman N, Higgins M, Abujudeh H, Charalel RA, Guimaraes MS, Gupta A, Lam A, Majdalany BS, Patel PJ, Stadtlander KS, Stillwell T, Teo EYL, Tong RT, Kapoor BS. ACR Appropriateness Criteria® Central Venous Access Device and Site Selection. J Am Coll Radiol. 2023 05; 20(5S):S3-S19.
Wu X, Heller M, Kwong A, Fidelman N, Mehta N. Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates. J Vasc Interv Radiol. 2023 07; 34(7):1237-1246.e3.
Wu X, Heller M, Lokken RP, Fidelman N, Lam A. Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study. J Vasc Interv Radiol. 2023 05; 34(5):815-823.e1.
Fidelman N, Atreya CE, Griffith M, Milloy MA, Carnevale J, Cinar P, Venook AP, Van Loon K. Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases. BMC Cancer. 2022 Dec 13; 22(1):1307.
Expert Panel on Interventional Radiology, Lam A, Kim YJ, Fidelman N, Higgins M, Cash BD, Charalel RA, Guimaraes MS, Kwan SW, Patel PJ, Plett S, Scali ST, Stadtlander KS, Stoner M, Tong R, Kapoor BS. ACR Appropriateness Criteria® Radiologic Management of Mesenteric Ischemia: 2022 Update. J Am Coll Radiol. 2022 11; 19(11S):S433-S444.
Fidelman N. Correction to: A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol. Cardiovasc Intervent Radiol. 2022 May; 45(5):719.
Fidelman N. A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol. Cardiovasc Intervent Radiol. 2022 04; 45(4):413-414.
Chen KS, Lawhn-Heath C, Behr S, Juarez R, Whitman J, Paciorek A, Nakakura EK, Fidelman N, Feng MU, Bergsland EK, Anwar M. Outcomes after high-dose radiation in the management of neuroendocrine neoplasms. PLoS One. 2021; 16(6):e0252574.
Keenan BP, VAN Loon K, Khilnani AD, Fidelman N, Behr SC, Atreya CE, Oh DY. Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy. Anticancer Res. 2021 Jun; 41(6):2985-2992.
Abi-Jaoudeh N, Dayyani F, Chen PJ, Fernando D, Fidelman N, Javan H, Liang PC, Hwang JI, Imagawa DK. Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021; 8:421-434.
Lee AY, Lehrman ED, Perito ER, Kerlan RK, Kohi MP, Kolli KP, Taylor AG, Ostroff JW, Kang SM, Roberts JP, Rhee S, Rosenthal P, Fidelman N. Non-operative management of biliary complications after Liver Transplantation in pediatric patients: A 30-year experience. Pediatr Transplant. 2021 Sep; 25(6):e14028.
Expert Panel on Interventional Radiology, Karuppasamy K, Kapoor BS, Fidelman N, Abujudeh H, Bartel TB, Caplin DM, Cash BD, Citron SJ, Farsad K, Gajjar AH, Guimaraes MS, Gupta A, Higgins M, Marin D, Patel PJ, Pietryga JA, Rochon PJ, Stadtlander KS, Suranyi PS, Lorenz JM. ACR Appropriateness Criteria® Radiologic Management of Lower Gastrointestinal Tract Bleeding: 2021 Update. J Am Coll Radiol. 2021 May; 18(5S):S139-S152.
Kohlbrenner R, Fidelman N, Kohi MP, Kumar V, Kolli KP. Onyx embolization of an enlarging arterioportal pancreatic AVM using a balloon-occlusion microcatheter. Diagn Interv Radiol. 2021 05; 27(3):458-459.
Heller M, Parikh ND, Fidelman N, Owen D. Frontiers of therapy for hepatocellular carcinoma. Abdom Radiol (NY). 2021 08; 46(8):3648-3659.
Lokken RP, Kerlan RK, Chung YC, Chen YF, Mehta NJ, Yao FY, Fidelman N. Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma. AJR Am J Roentgenol. 2021 05; 216(5):1283-1290.
Yao FY, Fidelman N, Mehta N. The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma. Semin Liver Dis. 2021 05; 41(2):117-127.
Lehrman ED, Fidelman N. Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide Therapy. Semin Intervent Radiol. 2020 Dec; 37(5):499-507.
Price A, Schwertner A, Tran D, Kohi M, Pallav Kolli K, Taylor A, Fidelman N. Outcomes of transjugular liver biopsies for liver transplant recipients with bicaval and piggyback hepatic vein anastomoses. Acta Radiol. 2021 Dec; 62(12):1537-1547.
Maddali MV, Chiu C, Cedarbaum ER, Yogeswaran V, Seedahmed M, Smith W, Bergsland E, Fidelman N, Kennedy JLW. Carcinoid Crisis-Induced Acute Systolic Heart Failure. JACC Case Rep. 2020 Nov; 2(13):2068-2071.
Lawhn-Heath C, Fidelman N, Chee B, Jivan S, Armstrong E, Zhang L, Lindsay S, Bergsland EK, Hope TA. Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors. J Nucl Med. 2021 02; 62(2):221-227.
Knox J, Kohlbrenner R, Kolli K, Fidelman N, Kohi MP, Lehrman E, Lokken RP, Zagoria R, Kerlan RK, LaBerge J, Taylor AG. Intermediate to Long-Term Clinical Outcomes of Percutaneous Cryoablation for Renal Masses. J Vasc Interv Radiol. 2020 Aug; 31(8):1242-1248.
Expert Panel on Interventional Radiology, Farsad K, Kapoor BS, Fidelman N, Cain TR, Caplin DM, Eldrup-Jorgensen J, Gupta A, Higgins M, Hohenwalter EJ, Lee MH, McBride JJ, Minocha J, Rochon PJ, Sutphin PD, Lorenz JM. ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis. J Am Coll Radiol. 2020 May; 17(5S):S255-S264.
Fidelman N. Holmium-166 radioembolisation after peptide receptor radionuclide therapy: much needed data to help inform future research. Lancet Oncol. 2020 04; 21(4):478-479.
Hope TA, Bodei L, Chan JA, El-Haddad G, Fidelman N, Kunz PL, Mailman J, Menda Y, Metz DC, Mittra ES, Pryma DA, Reidy-Lagunes DL, Singh S, Strosberg JR. NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy. J Nucl Med. 2020 02; 61(2):222-227.
Lebares CC, Graves CE, Lin MY, Fidelman N, Cello J, Harrison MR, Rogers S. Endoscopic Magnetic Compression Anastomosis For Small Bowel Bypass in a High Operative Risk Setting. Surg Laparosc Endosc Percutan Tech. 2019 Oct; 29(5):e84-e87.
Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK. Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve. J Hepatocell Carcinoma. 2019; 6:93-103.
Expert Panel on Interventional Radiology:, Minocha J, Smith AM, Kapoor BS, Fidelman N, Cain TR, Caplin DM, Eldrup-Jorgensen J, Farsad K, Gupta A, Lee MH, McBride JJ, Moores LK, Rochon PJ, Lorenz JM. ACR Appropriateness Criteria® Radiologic Management of Venous Thromboembolism-Inferior Vena Cava Filters. J Am Coll Radiol. 2019 May; 16(5S):S214-S226.
Knox J, Watson E, Fidelman N, Taylor AG, Kolli K, Lehrman E, Kohlbrenner R, Kohi MP. Outcomes after Peripancreatic Fluid Drainage in Patients with Simultaneous Pancreas-Kidney Transplantation. J Vasc Interv Radiol. 2019 Jun; 30(6):918-921.
Kwon DH, Paciorek A, Mulvey CK, Chan H, Fidelman N, Meng L, Nakakura EK, Zhang L, Bergsland EK, Van Loon K. Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases. Pancreas. 2019 04; 48(4):496-503.
Lee KA, Taylor A, Bartolome B, Fidelman N, Kolli KP, Kohi M, Kohlbrenner R, Laberge J, Lehrman E, Kerlan R. Safety and Efficacy of Transjugular Liver Biopsy in Patients with Left Lobe-Only Liver Transplants. J Vasc Interv Radiol. 2019 Jul; 30(7):1043-1047.
Kohlbrenner R, Lehrman ED, Taylor AG, Kohi MP, Fidelman N, Kumar V, Conrad M, Kolli KP. Operator Dose Reduction during Transjugular Liver Biopsy Using a Radiation-Attenuating Drape: A Prospective, Randomized Study. J Vasc Interv Radiol. 2018 09; 29(9):1248-1253.
Devulapalli KK, Fidelman N, Soulen MC, Miller M, Johnson MS, Addo E, El-Haddad G, Nutting C, Morrison J, Farsad K, Lokken RP, Gaba RC, Fleming J, Brown DB, Kwan SW, Rose SC, Pennycooke KA, Liu DM, White SB, Gandhi R, Lazar AA, Kerlan RK. 90Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections. Radiology. 2018 Sep; 288(3):774-781.
Expert Panel on Interventional Radiology:, Fidelman N, AbuRahma AF, Cash BD, Kapoor BS, Knuttinen MG, Minocha J, Rochon PJ, Shaw CM, Ray CE, Lorenz JM. ACR Appropriateness Criteria® Radiologic Management of Mesenteric Ischemia. J Am Coll Radiol. 2017 May; 14(5S):S266-S271.
Kohlbrenner R, Kolli KP, Taylor AG, Kohi MP, Lehrman ED, Fidelman N, Conrad M, LaBerge JM, Kerlan RK, Gould R. Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform. J Vasc Interv Radiol. 2017 Aug; 28(8):1129-1135.e1.
Kohi MP, Kohlbrenner R, Kolli KP, Lehrman E, Taylor AG, Fidelman N. Catheter directed interventions for acute deep vein thrombosis. Cardiovasc Diagn Ther. 2016 Dec; 6(6):599-611.
Peter Lokken R, Fidelman N, Pallav Kolli K, Kerlan RK. Letters to the Editor. J Vasc Interv Radiol. 2016 12; 27(12):1938-1939.
Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP. Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol. 2016 Dec; 7(6):860-874.
Ehman EC, Umetsu SE, Ohliger MA, Fidelman N, Ferrell LD, Yeh BM, Yee J, Hope TA. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdom Radiol (NY). 2016 11; 41(11):2161-2168.
Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H, Hwang W, Sze DY, Kothary N, Stashek K, Wileyto EP, Salem R, Metz DC, Soulen MC. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival. Cardiovasc Intervent Radiol. 2017 Jan; 40(1):69-80.
Lokken RP, Fidelman N, Kolli KP, Kerlan RK. Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries. J Vasc Interv Radiol. 2016 Nov; 27(11):1698-1704.
Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, Hope TA. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY). 2016 05; 41(5):963-9.
Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl. 2016 Feb; 22(2):178-87.
Yao FY, Fidelman N. Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging? Hepatology. 2016 Mar; 63(3):1014-25.
Kohi MP, Fidelman N, Behr S, Taylor AG, Kolli K, Conrad M, Hwang G, Weinstein S. Periprocedural Patient Care. Radiographics. 2015 Oct; 35(6):1766-78.
Kohi MP, Rizzuto GA, Fidelman N, Lucero J, Thiet MP. Retained Placenta Accreta Mimicking Choriocarcinoma. Case Rep Pathol. 2015; 2015:167986.
Fidelman N, Kerlan RK. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. AJR Am J Roentgenol. 2015 Oct; 205(4):742-52.
Olorunsola OG, Kohi MP, Behr SC, Kolli PK, Taylor AG, Tong RT, LaBerge JM, Kerlan RK, Fidelman N. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization. J Vasc Interv Radiol. 2015 Oct; 26(10):1472-8.
Kohlbrenner R, Kolli KP, Taylor AG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK, Agarwal VK, Lehrman ED, Nanavati S, Avrin DE, Gould R. Patient Radiation Dose Reduction during Transarterial Chemoembolization Using a Novel X-Ray Imaging Platform. J Vasc Interv Radiol. 2015 Sep; 26(9):1331-8.
Kohi MP, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. Crossed legs: an unexpected occurrence during an ALN filter placement. Clin Imaging. 2015 Nov-Dec; 39(6):1128-9.
Fidelman N. Benign Biliary Strictures: Diagnostic Evaluation and Approaches to Percutaneous Treatment. Tech Vasc Interv Radiol. 2015 Dec; 18(4):210-7.
Bartolome B, Kohi MP, Fidelman N, Taylor AG, Kolli KP, LaBerge JM, Kerlan RK. Hemothorax resulting from injury to the right inferior phrenic artery following transhepatic procedures. J Vasc Interv Radiol. 2015 Apr; 26(4):600-1.
Young K, Fidelman N, Yao FY, Hills NK, Kohi MP, Kolli KP, Taylor AG, Kerlan RK. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma. Liver Transpl. 2015 Apr; 21(4):454-67.
Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8.
Kohi MP, Naeger DM, Lorenson MJ, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. Hook, line, and sinker: hook wire localization of a retained suture needle in the perineum. J Vasc Interv Radiol. 2014 Sep; 25(9):1479-80.
Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80.
Kohi MP, Agarwal VK, Naeger DM, Taylor AG, Kolli KP, Fidelman N, LaBerge JM, Kerlan RK. The inferior emissary vein: a reliable landmark for right adrenal vein sampling. Acta Radiol. 2015 Apr; 56(4):454-7.
Price AJ, Fidelman N, Wilson MW, Kerlan RK. Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomes. J Vasc Interv Radiol. 2014 Feb; 25(2):199-205.
Kuo YC, Kohi MP, Naeger DM, Tong RT, Kolli KP, Taylor AG, Laberge JM, Kerlan RK, Fidelman N. Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 2013 Oct; 36(5):1336-43.
Johnson DT, Durack JC, Fidelman N, Kerlan RK, LaBerge JM. Distribution of reported StarClose SE vascular closure device complications in the manufacturer and user facility device experience database. J Vasc Interv Radiol. 2013 Jul; 24(7):1051-6.
Olorunsola OG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK. Failure of filter reexpansion during unsuccessful retrieval of Option inferior vena cava filter. J Vasc Interv Radiol. 2013 Jul; 24(7):1065-7.
Veal DR, Lee AY, Kerlan RK, Gordon RL, Fidelman N. Outcomes of metallic biliary stent insertion in patients with malignant bilobar obstruction. J Vasc Interv Radiol. 2013 Jul; 24(7):1003-10.
Kohi MP, Fidelman N, Kerlan RK. Reply to Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jul; 24(7):1076.
Tong RT, Kohi M, Fidelman N, Kuo YC, Foster R, Peled A, Kolli KP, Taylor AG, LaBerge JM, Kerlan RK. Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction. J Vasc Interv Radiol. 2013 Sep; 24(9):1369-74.
Ray CE, Lorenz JM, Burke CT, Darcy MD, Fidelman N, Greene FL, Hohenwalter EJ, Kinney TB, Kolbeck KJ, Kostelic JK, Kouri BE, Nair AV, Owens CA, Rochon PJ, Rockey DC, Vatakencherry G. ACR Appropriateness Criteria radiologic management of benign and malignant biliary obstruction. J Am Coll Radiol. 2013 Aug; 10(8):567-74.
Kohi MP, Naeger DM, Kukreja J, Fidelman N, Laberge JM, Gordon RL, Kerlan RK. Preoperative CT-Guided percutaneous wire localization of ground glass pulmonary nodules with a modified Kopans wire. J Thorac Dis. 2013 Apr; 5(2):E31-4.
Olorunsola OG, Kohi MP, Fidelman N, Westphalen AC, Kolli PK, Taylor AG, Gordon RL, LaBerge JM, Kerlan RK. Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and Günther Tulip filters. J Vasc Interv Radiol. 2013 Apr; 24(4):566-71.
Wang SC, Fidelman N, Nakakura EK. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. Semin Oncol. 2013 Feb; 40(1):69-74.
Mehta N, Fidelman N, Sarkar M, Yao FY. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2013 May; 11(5):572-8.
Garwood ER, Fidelman N, Hoch SE, Kerlan RK, Yao FY. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl. 2013 Feb; 19(2):164-73.
Kouri BE, Funaki BS, Ray CE, Abou-Alfa GK, Burke CT, Darcy MD, Fidelman N, Greene FL, Harrison SA, Kinney TB, Kostelic JK, Lorenz JM, Nair AV, Nemcek AA, Owens CA, Saad WE, Vatakencherry G. ACR Appropriateness Criteria radiologic management of hepatic malignancy. J Am Coll Radiol. 2012 Dec; 9(12):919-25.
Arrayeh E, Fidelman N, Gordon RL, LaBerge JM, Kerlan RK, Klimov A, Bloom AI. Transcatheter arterial embolization for upper gastrointestinal nonvariceal hemorrhage: is empiric embolization warranted? Cardiovasc Intervent Radiol. 2012 Dec; 35(6):1346-54.
Kohi MP, Fidelman N, Naeger DM, LaBerge JM, Gordon RL, Kerlan RK. Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jan; 24(1):68-73.
Lee AY, Gregorius J, Kerlan RK, Gordon RL, Fidelman N. Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic bile duct injuries. PLoS One. 2012; 7(10):e46478.
Fidelman N, Qayyum A. Pretransplant prediction of microvascular invasion in patients with hepatocellular carcinoma: added value of diffusion-weighted magnetic resonance imaging. Liver Transpl. 2012 Oct; 18(10):1131-3.
Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK. The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol. 2012 Oct; 199(4):746-55.
Kwan SW, Fidelman N, Ma E, Kerlan RK, Yao FY. Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl. 2012 Jun; 18(6):727-36.
Lu MT, Tellis WM, Fidelman N, Qayyum A, Avrin DE. Reducing the rate of repeat imaging: import of outside images to PACS. AJR Am J Roentgenol. 2012 Mar; 198(3):628-34.
Ray CE, English B, Funaki BS, Burke CT, Fidelman N, Ginsburg ME, Kinney TB, Kostelic JK, Kouri BE, Lorenz JM, Nair AV, Nemcek AA, Owens CA, Saleh AG, Vatakencherry G, Mohammed TL. ACR appropriateness criteria® radiologic management of thoracic nodules and masses. J Am Coll Radiol. 2012 Jan; 9(1):13-9.
Durack JC, Thor Johnson D, Fidelman N, Kerlan RK, LaBerge JM. Entrapment of the StarClose Vascular Closure System after attempted common femoral artery deployment. Cardiovasc Intervent Radiol. 2012 Aug; 35(4):942-4.
Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011 Aug; 17(8):934-42.
Farrelly C, Fidelman N, Durack JC, Hagiwara E, Kerlan RK. Transcatheter arterial embolization of spontaneous life-threatening extraperitoneal hemorrhage. J Vasc Interv Radiol. 2011 Oct; 22(10):1396-402.
Kwan SW, Fidelman N, Durack JC, Roberts JP, Kerlan RK. Rex shunt preoperative imaging: diagnostic capability of imaging modalities. PLoS One. 2011; 6(7):e22222.
Fidelman N, Kerlan RK, Laberge JM, Gordon RL. Accuracy of percutaneous transhepatic cholangiography in predicting the location and nature of major bile duct injuries. J Vasc Interv Radiol. 2011 Jun; 22(6):884-92.
Tan JH, Fidelman N, Durack JC, Hays SR, Leard LL, Laberge JM, Kerlan RK, Golden JA, Gordon RL. Management of recurrent airway strictures in lung transplant recipients using AERO covered stents. J Vasc Interv Radiol. 2010 Dec; 21(12):1900-4.
Bhagat N, Fidelman N, Durack JC, Collins J, Gordon RL, LaBerge JM, Kerlan RK. Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol. 2010 Dec; 33(6):1186-91.
Fidelman N, Freed RC, Nakakura EK, Rosenberg J, Bloom AI. Arterial embolization for the management of gastrointestinal hemorrhage from metastatic renal cell carcinoma. J Vasc Interv Radiol. 2010 May; 21(5):741-4.
Fidelman N, Gordon RL, Bloom AI, LaBerge JM, Kerlan RK. Reperfusion of pulmonary arteriovenous malformations after successful embolotherapy with vascular plugs. J Vasc Interv Radiol. 2008 Aug; 19(8):1246-50.
Fidelman N, Bloom AI, Kerlan RK, Laberge JM, Wilson MW, Ring EJ, Gordon RL. Hepatic arterial injuries after percutaneous biliary interventions in the era of laparoscopic surgery and liver transplantation: experience with 930 patients. Radiology. 2008 Jun; 247(3):880-6.
Fidelman N, Allen D, Bloom AI, LaBerge JM, Hastings GS, Kerlan RK, Gordon RL, Wilson MW. Percutaneous interventions in subclavian artery-to-contralateral subclavian vein "necklace" hemodialysis grafts: experience in five patients. J Vasc Interv Radiol. 2007 May; 18(5):597-601.
Fidelman NA, Wilson MW, Bloom AI, Kerlan RK, LaBerge JM, Gordon RL. Orthopedic spinal and hip prostheses: effects of magnetic susceptibility artifacts during MR arteriography and venography of abdomen and pelvis. Radiology. 2006 Sep; 240(3):894-9.
Fidelman N, Wilson MW, Boddington S, Knoess N, Lutz J, Wolanske KA, Kerlan RK, Laberge JM, Gordon RL. Postoperative evaluation of complex aortovisceral and aortorenal reconstructions by magnetic resonance angiography. Acad Radiol. 2004 Sep; 11(9):1055-8.
Wilson MW, Kerlan RK, Fidelman NA, Venook AP, LaBerge JM, Koda J, Gordon RL. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients. Radiology. 2004 Jan; 230(1):287-93.
Wilson MW, Fidelman N, Weber OM, Martin AJ, Gordon RL, LaBerge JM, Kerlan RK, Wolanske KA, Saeed M. Experimental renal artery embolization in a combined MR imaging/angiographic unit. J Vasc Interv Radiol. 2003 Sep; 14(9 Pt 1):1169-75.
Wilson MW, Fidelman N, Lull RJ, Marder SR, Laberge JM, Kerlan RK, Gordon RL. Evaluation of active bleeding into hematomas by technetium-99m red blood cell scintigraphy before angiography. Clin Nucl Med. 2002 Nov; 27(11):763-6.
Fidelman N, Wilson MW, Weber OM, Martin AJ, Kerlan RK, LaBerge JM, Gordon RL. Real-time MR properties of particulate embolic agents tested in a dynamic flow model. J Vasc Interv Radiol. 2002 Jun; 13(6):613-8.
Redfern CH, Degtyarev MY, Kwa AT, Salomonis N, Cotte N, Nanevicz T, Fidelman N, Desai K, Vranizan K, Lee EK, Coward P, Shah N, Warrington JA, Fishman GI, Bernstein D, Baker AJ, Conklin BR. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci U S A. 2000 Apr 25; 97(9):4826-31.
Schaffer DV, Fidelman NA, Dan N, Lauffenburger DA. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng. 2000 Mar 05; 67(5):598-606.